COSCIENS Biopharma Inc T.AEZ

Primary Symbol: T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc

Bullboard Posts

Post by slagheapon May 10, 2016 9:28pm

107 Views

Post# 24860307

tight float

Name of Nominee

	Votes For	%	Votes Withheld	%
Michael Cardiff	1,254,909	88.53	162,647	11.47
David A. Dodd	1,187,024	83.74	230,532	16.26
Carolyn Egbert	1,268,485	89.48	149,071	10.52
Juergen Ernst	1,266,892	89.37	150,664	10.63
Grard Limoges	1,268,600	89.49	148,956	10.51
Ken Newport	1,254,215	88.48	163,341	11.52